BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 14, 2008
View Archived Issues
Characterization of gene expression after ABR-215757 therapy in systemic lupus erythematosus
Read More
Dose escalation continues in phase II study of voreloxin in platinum-resistant ovarian cancer
Read More
TRU-015 retreatment well tolerated, maintains responses in rheumatoid arthritis patients
Read More
3SBio files for SFDA approval of NuLeusin in China
Read More
Telik enters discovery agreement for musculoskeletal and autoimmune diseases
Read More
Avastin provides an additional 4 months of life in patients with lung cancer
Read More
Chelsea commences phase I clinical trial of CH-4051
Read More
CVBT collaborates with Cardio Neo-Genesis for coronary heart disease candidate
Read More
FDA approves low-dose Premarin regimen to treat postmenopausal dyspareunia
Read More
Genentech licenses Ex-U.S. rights to GDC-0449 to Roche
Read More
DPD-207 active against Staphylococcus aureus in murine infection model
Read More
XF-73 activity, resistance examined in Staphylococcus aureus studies
Read More
Phase I results confirm tolerability, immunogenicity of cytomegalovirus vaccine
Read More
DSTL to evaluate Novacta's lantibiotics as broad-spectrum antiviral treatment
Read More
Antigen-pulsed dendritic cell-based vaccine feasible and safe in glioblastoma patients
Read More
Antitope and Isu Abxis sign research collaboration in therapeutic monoclonal antibodies
Read More
Lexicon announces completion of phase Ib trial of LX-1032 for carcinoid syndrome
Read More
Affymax completes enrollment in EMERALD 1 phase III clinical trial of Hematide
Read More
FDA designates as complete AMAG's resubmission for ferumoxytol NDA in CKD
Read More
Recent Ranbaxy patents disclose novel agents for inflammatory disorders
Read More
BioSeek licenses two antiinflammatory peptides from Amylin
Read More
IRM reports novel antiobesity compounds in a recent patent
Read More
New treatment strategies for transplant rejection described in recent patent lterature
Read More
ISTA files NDA with the FDA for Bepreve in allergic conjunctivitis ocular itching
Read More
NDA filed for Trelstar 6-month formulation for prostate cancer
Read More